Bank of New York Mellon’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-60,405
| Closed | -$33K | – | 4402 |
|
|
2016
Q3 | $33K | Sell |
60,405
-12,522
| -17% | -$6.84K | ﹤0.01% | 4182 |
|
|
2016
Q2 | $43K | Sell |
72,927
-172,632
| -70% | -$102K | ﹤0.01% | 4199 |
|
|
2016
Q1 | $358K | Buy |
245,559
+1,187
| +0.5% | +$1.73K | ﹤0.01% | 3566 |
|
|
2015
Q4 | $782K | Buy |
244,372
+17,983
| +8% | +$57.5K | ﹤0.01% | 3307 |
|
|
2015
Q3 | $1.42M | Sell |
226,389
-6,216
| -3% | -$38.9K | ﹤0.01% | 2945 |
|
|
2015
Q2 | $2.31M | Buy |
232,605
+71,850
| +45% | +$714K | ﹤0.01% | 2810 |
|
|
2015
Q1 | $1.19M | Buy |
160,755
+7,075
| +5% | +$52.2K | ﹤0.01% | 3208 |
|
|
2014
Q4 | $822K | Buy |
153,680
+2,676
| +2% | +$14.3K | ﹤0.01% | 3411 |
|
|
2014
Q3 | $760K | Buy |
151,004
+1,770
| +1% | +$8.91K | ﹤0.01% | 3447 |
|
|
2014
Q2 | $1M | Buy |
149,234
+110,049
| +281% | +$739K | ﹤0.01% | 3311 |
|
|
2014
Q1 | $284K | Buy |
39,185
+7,769
| +25% | +$56.3K | ﹤0.01% | 3745 |
|
|
2013
Q4 | $118K | Buy |
+31,416
| New | +$118K | ﹤0.01% | 3938 |
|